| Name | Title | Contact Details |
|---|
A leading specialty formulator and contract manufacturer of enzyme and probiotic-based dietary supplements.
Georgetown Health Care Ctr is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
LAB Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 2019 when Anne Arundel Medical Center and Doctors Community Medical Center came together to form one health system, Luminis Health is sparking a new path forward. With 595 beds across three hospitals, we currently serve seven counties in the heart of central Maryland. Our team is made up of more than 9,000 medical staff, employees and volunteers – all of whom are committed to illuminating new possibilities in health care and for our community. Thanks to them, U.S. News & World Report has deemed AAMC a top hospital in the region and the Maryland Institute for Emergency Medical Services Systems has named DCMC a primary stroke center – just to name a few accolades. We have also earned national recognition in cancer care, stroke care, innovation and patient satisfaction. We can`t wait to see what`s next.